Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
1(17%)
Results Posted
0%(0 trials)

Phase Distribution

Ph early_phase_1
2
33%
Ph phase_4
1
17%

Phase Distribution

2

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Early Phase 1First-in-human
2(66.7%)
Phase 4Post-market surveillance
1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(5)

Detailed Status

Completed5
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (66.7%)
Phase 41 (33.3%)

Trials by Status

recruiting117%
completed583%

Recent Activity

1 active trials
Showing 5 of 6
recruiting

Gas6 and Soluble MerTK in Periodontal Diseases

NCT07535177
completed

Interleukin- 17 (IL-17), Bcl-3, and NF-kappa-B Inhibitor Zeta (IκBζ) Expression Levels in the Psoriasis Patients

NCT06408454
completed

Maternal Periodontal Status and Cytokines in Preeclampsia

NCT03088228
completedphase_4

Changes of GCF Levels of RANKL and Osteoprotegerin in Postmenopausal Osteoporosis

NCT02808988
completedearly_phase_1

Chemerin and Interleukin-6 Levels of Gingival Crevicular Fluid in Obese Individuals Following Periodontal Treatment

NCT02660814
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT07535177

Gas6 and Soluble MerTK in Periodontal Diseases

Recruiting
NCT06408454

Interleukin- 17 (IL-17), Bcl-3, and NF-kappa-B Inhibitor Zeta (IκBζ) Expression Levels in the Psoriasis Patients

Completed
NCT03088228

Maternal Periodontal Status and Cytokines in Preeclampsia

Completed
NCT02808988Phase 4

Changes of GCF Levels of RANKL and Osteoprotegerin in Postmenopausal Osteoporosis

Completed
NCT02660814Early Phase 1

Chemerin and Interleukin-6 Levels of Gingival Crevicular Fluid in Obese Individuals Following Periodontal Treatment

Completed
NCT02563171Early Phase 1

Gingival Crevicular Fluid Vaspin and Omentin Levels in Obese Patients With Chronic Periodontitis

Completed

All 6 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
6